{"originalText": "，患者自述于2016年2月因发热、腹痛就诊于我院急诊外科，完善相关检查示乙状结肠占位、乙状结肠穿孔，遂于2016-2-26于我院胃肠外科行乙状结肠癌切除术、远端闭锁、近端造瘘术，，术后病理：低分化管状腺癌，肿物浸透侵及外膜，肠壁组织伴炎性改变，淋巴结转移不详，病理号Z0520138，，术后分期：PT4BNXM0。，免疫组化：，A2:CK(+)CDX2(+)S-100(-)CD34(血管+V0)KI-67(约30%+）P53(+++)SYNAPTOPL(+)，术后腹痛等不适消失。于2016-4-8予患者XELOX方案化疗1周期，，具体为：奥沙利铂200MGD1静滴，希罗达1500MGD1-14日双次口服，化疗过程顺利。于2016年4月17日因胆囊炎入我院急诊对症治疗，停希罗达口服治疗。现为进一步治疗入我科。患者1个月来饮食较差，睡眠可，精神体力可，造瘘口偶有腹泻症状，排尿正常，体重减轻4KG，周身无疼痛，ECOG评分1分。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 43, "end_pos": 49}, {"label_type": "手术", "overlap": 0, "start_pos": 69, "end_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 113}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 271}, {"end_pos": 288, "label_type": "药物", "overlap": 0, "start_pos": 285}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 324, "end_pos": 327}, {"end_pos": 341, "label_type": "药物", "overlap": 0, "start_pos": 338}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}]}
